Teva Pharmaceutical Industries Limited (TEVA)
USD 21.2
(1.53%)
USD 21.2
(1.53%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 433 Million USD | -84.52% |
| 2022 | 2.79 Billion USD | -12.54% |
| 2021 | 3.19 Billion USD | 4.75% |
| 2020 | 3.05 Billion USD | 9.15% |
| 2019 | 2.79 Billion USD | 270.86% |
| 2018 | -1.63 Billion USD | 90.64% |
| 2017 | -17.48 Billion USD | -911.7% |
| 2016 | 2.15 Billion USD | -35.74% |
| 2015 | 3.35 Billion USD | -15.16% |
| 2014 | 3.95 Billion USD | 139.6% |
| 2013 | 1.64 Billion USD | -25.22% |
| 2012 | 2.2 Billion USD | -29.08% |
| 2011 | 3.1 Billion USD | -19.68% |
| 2010 | 3.87 Billion USD | 60.96% |
| 2009 | 2.4 Billion USD | 110.04% |
| 2008 | 1.14 Billion USD | -52.19% |
| 2007 | 2.39 Billion USD | 199.0% |
| 2006 | 801 Million USD | -38.99% |
| 2005 | 1.31 Billion USD | 127.22% |
| 2004 | 577.8 Million USD | -34.15% |
| 2003 | 877.4 Million USD | 67.44% |
| 2002 | 524 Million USD | 45.24% |
| 2001 | 360.79 Million USD | 47.55% |
| 2000 | 244.52 Million USD | 22.85% |
| 1999 | 199.04 Million USD | 37.27% |
| 1998 | 145 Million USD | -16.57% |
| 1997 | 173.8 Million USD | 34.42% |
| 1996 | 129.3 Million USD | 12.24% |
| 1995 | 115.2 Million USD | 7.97% |
| 1994 | 106.7 Million USD | 21.25% |
| 1993 | 88 Million USD | 57.14% |
| 1992 | 56 Million USD | 7.49% |
| 1991 | 52.1 Million USD | 29.28% |
| 1990 | 40.3 Million USD | -8.82% |
| 1989 | 44.2 Million USD | 96.44% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 656 Million USD | -9.14% |
| 2024 Q2 | 814 Million USD | 24.09% |
| 2023 Q2 | -646 Million USD | -226.92% |
| 2023 Q1 | 509 Million USD | -31.49% |
| 2023 FY | 433 Million USD | -84.52% |
| 2023 Q4 | 722 Million USD | 103.38% |
| 2023 Q3 | 355 Million USD | 154.95% |
| 2022 Q3 | 672 Million USD | 170.81% |
| 2022 Q1 | 688 Million USD | 782.05% |
| 2022 FY | 2.79 Billion USD | -12.54% |
| 2022 Q2 | -949 Million USD | -237.94% |
| 2022 Q4 | 743 Million USD | 10.57% |
| 2021 Q3 | 623 Million USD | 7.04% |
| 2021 FY | 3.19 Billion USD | 4.75% |
| 2021 Q2 | 582 Million USD | 34.1% |
| 2021 Q4 | 78 Million USD | -87.48% |
| 2021 Q1 | 434 Million USD | 6.9% |
| 2020 FY | 3.05 Billion USD | 9.15% |
| 2020 Q3 | -4.34 Billion USD | -2609.83% |
| 2020 Q4 | 406 Million USD | 109.35% |
| 2020 Q2 | 173 Million USD | -9.42% |
| 2020 Q1 | 191 Million USD | 29.05% |
| 2019 Q2 | -644 Million USD | -580.6% |
| 2019 FY | 2.79 Billion USD | 270.86% |
| 2019 Q1 | 134 Million USD | 104.24% |
| 2019 Q3 | -81 Million USD | 87.42% |
| 2019 Q4 | 148 Million USD | 282.72% |
| 2018 FY | -1.63 Billion USD | 90.64% |
| 2018 Q1 | 1.52 Billion USD | 111.72% |
| 2018 Q2 | -14 Million USD | -100.92% |
| 2018 Q4 | -3.16 Billion USD | -19875.0% |
| 2018 Q3 | 16 Million USD | 214.29% |
| 2017 Q2 | -5.74 Billion USD | -741.34% |
| 2017 Q4 | -13.01 Billion USD | -3543.65% |
| 2017 Q3 | 378 Million USD | 106.59% |
| 2017 FY | -17.48 Billion USD | -911.7% |
| 2017 Q1 | 895 Million USD | 753.28% |
| 2016 FY | 2.15 Billion USD | -35.74% |
| 2016 Q1 | 1.16 Billion USD | 25.13% |
| 2016 Q2 | 361 Million USD | -69.01% |
| 2016 Q3 | 765 Million USD | 111.91% |
| 2016 Q4 | -137 Million USD | -117.91% |
| 2015 Q4 | 931 Million USD | -7.82% |
| 2015 FY | 3.35 Billion USD | -15.16% |
| 2015 Q3 | 1.01 Billion USD | 52.57% |
| 2015 Q2 | 662 Million USD | -11.62% |
| 2015 Q1 | 749 Million USD | -20.49% |
| 2014 Q3 | 1.11 Billion USD | 20.22% |
| 2014 FY | 3.95 Billion USD | 139.6% |
| 2014 Q1 | 972 Million USD | 73.57% |
| 2014 Q2 | 925 Million USD | -4.84% |
| 2014 Q4 | 942 Million USD | -15.29% |
| 2013 Q3 | 801 Million USD | 236.69% |
| 2013 FY | 1.64 Billion USD | -25.22% |
| 2013 Q1 | 874 Million USD | 164.85% |
| 2013 Q2 | -586 Million USD | -167.05% |
| 2013 Q4 | 560 Million USD | -30.09% |
| 2012 Q1 | 928 Million USD | 52.13% |
| 2012 Q4 | 330 Million USD | 650.0% |
| 2012 Q3 | -60 Million USD | -105.96% |
| 2012 Q2 | 1 Billion USD | 8.51% |
| 2012 FY | 2.2 Billion USD | -29.08% |
| 2011 FY | 3.1 Billion USD | -19.68% |
| 2011 Q4 | 610 Million USD | -41.06% |
| 2011 Q1 | 867 Million USD | 12.02% |
| 2011 Q2 | -597 Million USD | -168.86% |
| 2011 Q3 | 1.03 Billion USD | 273.37% |
| 2010 Q1 | 834 Million USD | 102.43% |
| 2010 FY | 3.87 Billion USD | 60.96% |
| 2010 Q4 | 774 Million USD | -34.85% |
| 2010 Q3 | 1.18 Billion USD | 10.51% |
| 2010 Q2 | 1.07 Billion USD | 28.9% |
| 2009 Q2 | 702 Million USD | 30.48% |
| 2009 Q1 | 538 Million USD | 230.58% |
| 2009 FY | 2.4 Billion USD | 110.04% |
| 2009 Q3 | 753 Million USD | 7.26% |
| 2009 Q4 | 412 Million USD | -45.29% |
| 2008 Q2 | 638 Million USD | 114.81% |
| 2008 Q4 | -412 Million USD | -166.24% |
| 2008 FY | 1.14 Billion USD | -52.19% |
| 2008 Q1 | 297 Million USD | -55.07% |
| 2008 Q3 | 622 Million USD | -2.51% |
| 2007 Q4 | 661 Million USD | 1.54% |
| 2007 Q1 | 446 Million USD | 18.68% |
| 2007 FY | 2.39 Billion USD | 199.0% |
| 2007 Q2 | 637 Million USD | 42.83% |
| 2007 Q3 | 651 Million USD | 2.2% |
| 2006 Q3 | 723.6 Million USD | 11.77% |
| 2006 Q1 | -945.8 Million USD | -361.85% |
| 2006 FY | 801 Million USD | -38.99% |
| 2006 Q4 | 375.8 Million USD | -48.07% |
| 2006 Q2 | 647.4 Million USD | 168.45% |
| 2005 Q1 | 330.9 Million USD | -1.34% |
| 2005 Q4 | 361.2 Million USD | 15.7% |
| 2005 Q3 | 312.2 Million USD | 1.17% |
| 2005 Q2 | 308.6 Million USD | -6.74% |
| 2005 FY | 1.31 Billion USD | 127.22% |
| 2004 Q2 | 297.1 Million USD | 179.78% |
| 2004 FY | 577.8 Million USD | -34.15% |
| 2004 Q4 | 335.4 Million USD | 5.57% |
| 2004 Q3 | 317.7 Million USD | 6.93% |
| 2004 Q1 | -372.4 Million USD | -264.42% |
| 2003 Q1 | 179.3 Million USD | -1.81% |
| 2003 Q4 | 226.5 Million USD | 14.92% |
| 2003 FY | 877.4 Million USD | 67.44% |
| 2003 Q3 | 197.1 Million USD | -28.2% |
| 2003 Q2 | 274.5 Million USD | 53.1% |
| 2002 Q3 | 121.6 Million USD | 8.96% |
| 2002 Q2 | 111.6 Million USD | 3.14% |
| 2002 Q4 | 182.6 Million USD | 50.16% |
| 2002 Q1 | 108.2 Million USD | 12.6% |
| 2002 FY | 524 Million USD | 45.24% |
| 2001 Q1 | 78.9 Million USD | 74.29% |
| 2001 Q3 | 99 Million USD | 13.99% |
| 2001 Q2 | 86.85 Million USD | 10.07% |
| 2001 FY | 360.79 Million USD | 47.55% |
| 2001 Q4 | 96.09 Million USD | -2.94% |
| 2000 Q1 | 55.99 Million USD | -9.16% |
| 2000 FY | 244.52 Million USD | 22.85% |
| 2000 Q3 | 74.42 Million USD | 8.11% |
| 2000 Q4 | 45.27 Million USD | -39.17% |
| 2000 Q2 | 68.83 Million USD | 22.93% |
| 1999 Q2 | 44.7 Million USD | 9.29% |
| 1999 Q1 | 40.9 Million USD | -10.89% |
| 1999 Q4 | 61.64 Million USD | 19.47% |
| 1999 FY | 199.04 Million USD | 37.27% |
| 1999 Q3 | 51.6 Million USD | 15.44% |
| 1998 Q1 | 35.6 Million USD | 105.47% |
| 1998 FY | 145 Million USD | -16.57% |
| 1998 Q2 | 23.6 Million USD | -33.71% |
| 1998 Q3 | 39.7 Million USD | 68.22% |
| 1998 Q4 | 45.9 Million USD | 15.62% |
| 1997 Q2 | 270.7 Million USD | 1.16% |
| 1997 FY | 173.8 Million USD | 34.42% |
| 1997 Q3 | 286.7 Million USD | 5.91% |
| 1997 Q4 | -651.2 Million USD | -327.14% |
| 1997 Q1 | 267.6 Million USD | 148.94% |
| 1996 Q4 | -546.8 Million USD | -331.11% |
| 1996 Q3 | 236.6 Million USD | -5.44% |
| 1996 Q2 | 250.2 Million USD | 32.17% |
| 1996 Q1 | 189.3 Million USD | 152.64% |
| 1996 FY | 129.3 Million USD | 12.24% |
| 1995 Q1 | 152.7 Million USD | 147.66% |
| 1995 Q3 | 165.3 Million USD | 5.42% |
| 1995 Q2 | 156.8 Million USD | 2.69% |
| 1995 FY | 115.2 Million USD | 7.97% |
| 1995 Q4 | -359.6 Million USD | -317.54% |
| 1994 Q1 | 136.7 Million USD | 148.36% |
| 1994 FY | 106.7 Million USD | 21.25% |
| 1994 Q4 | -320.4 Million USD | -323.28% |
| 1994 Q3 | 143.5 Million USD | -2.31% |
| 1994 Q2 | 146.9 Million USD | 7.46% |
| 1993 Q4 | -282.7 Million USD | -322.25% |
| 1993 Q3 | 127.2 Million USD | 1.76% |
| 1993 Q1 | 118.4 Million USD | 154.11% |
| 1993 FY | 88 Million USD | 57.14% |
| 1993 Q2 | 125 Million USD | 5.57% |
| 1992 Q4 | -218.8 Million USD | -335.27% |
| 1992 Q2 | 93 Million USD | 0.11% |
| 1992 Q1 | 92.9 Million USD | 148.31% |
| 1992 Q3 | 93 Million USD | 0.0% |
| 1992 FY | 56 Million USD | 7.49% |
| 1991 Q2 | 77.8 Million USD | -10.88% |
| 1991 Q4 | -192.3 Million USD | -344.35% |
| 1991 Q1 | 87.3 Million USD | 158.67% |
| 1991 Q3 | 78.7 Million USD | 1.16% |
| 1991 FY | 52.1 Million USD | 29.28% |
| 1990 FY | 40.3 Million USD | -8.82% |
| 1990 Q1 | 65.7 Million USD | 143.34% |
| 1990 Q2 | 69.6 Million USD | 5.94% |
| 1990 Q3 | 62.6 Million USD | -10.06% |
| 1990 Q4 | -148.8 Million USD | -337.7% |
| 1989 Q3 | 63.8 Million USD | -7.27% |
| 1989 Q2 | 68.8 Million USD | 0.88% |
| 1989 Q1 | 68.2 Million USD | 155.81% |
| 1989 Q4 | -151.6 Million USD | -337.62% |
| 1989 FY | 44.2 Million USD | 96.44% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 204.37 Million USD | -111.866% |
| Bausch Health Companies Inc. | 963 Million USD | 55.036% |
| Catalent, Inc. | -749 Million USD | 157.81% |
| Emergent BioSolutions Inc. | -726.4 Million USD | 159.609% |
| Elanco Animal Health Incorporated | 326 Million USD | -32.822% |
| Perrigo Company plc | 151.9 Million USD | -185.056% |
| Zoetis Inc. | 3.06 Billion USD | 85.891% |